A PHASE I OPEN LABEL SAFETY AND PHARMACOKINETIC STUDY OF SGT-53

SGT-53 的 I 期开放标签安全性和药代动力学研究

• 批准号: 7719057
• 负责人: JOHN L. MARSHALL
• 金额: $ 0.14万
• 依托单位: GEORGETOWN UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2008
• 资助国家: 美国
• 起止时间: 2008-04-01 至 2009-03-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7719057
• 关键词: Adverse event; Clinical; Computer Retrieval of Information on Scientific Projects Database; Dose; Drug Kinetics; Funding; Grant; Institution; Label; Laboratories; Phase; Physical Examination; Research; Research Personnel; Resources; Safety; Source; Testing; United States National Institutes of Health; Week

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The primary objective of this study is to evaluate the safety of escalating doses of SGT-53 administered over a course of 5 weeks. Safety will be assessed by analysis of adverse experiences, clinical laboratory tests, and physical examinations.

这个子项目是许多研究子项目中的一个 由NIH/NCRR资助的中心赠款提供的资源。子项目和 研究者（PI）可能从另一个NIH来源获得了主要资金， 因此可以在其他CRISP条目中表示。所列机构为 研究中心，而研究中心不一定是研究者所在的机构。 本研究的主要目的是评价SGT-53递增剂量给药5周的安全性。将通过分析不良经历、临床实验室检查和体格检查来评估安全性。